Petros Pharmaceuticals, Inc.
PTPI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $79 | $45 | $121 | $907 |
| - Cash | $4 | $13 | $9 | $24 |
| + Debt | $7 | $8 | $10 | $0 |
| Enterprise Value | $83 | $40 | $121 | $883 |
| Revenue | $5 | $6 | $6 | $8 |
| % Growth | -12.2% | -2.8% | -23.3% | – |
| Gross Profit | $4 | $4 | $4 | $6 |
| % Margin | 76.3% | 72% | 61.8% | 79.5% |
| EBITDA | -$11 | -$4 | -$14 | -$2 |
| % Margin | -211.5% | -72.3% | -229.1% | -22.3% |
| Net Income | -$14 | -$8 | -$20 | -$9 |
| % Margin | -280.1% | -140.2% | -334.4% | -115% |
| EPS Diluted | -3.34 | -6.35 | -9.68 | -8.25 |
| % Growth | 47.4% | 34.4% | -17.3% | – |
| Operating Cash Flow | -$3 | -$8 | -$13 | -$12 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$3 | -$8 | -$13 | -$12 |